Search

everythinglearnresearchcommunity

for

Search:↓

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Two main types of fibroblasts with unique functions and additional subtypes were identified in human skin.

The ZIP7 gene helps control zinc levels in cells by moving zinc from the Golgi apparatus to the cytoplasm.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.